Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gialdroni-Grassi

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 1, 1995
In vitro effect of bombesin-related peptides on the procoagulant activity of alveolar macrophagesF Meloni, A Saporiti, P Ballabio, et al.
Chemotherapy|July 1, 1995
Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytesF Meloni, P Ballabio, L Bianchi, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Bactericidal activity of meropenem and interactions with other antibioticsA Ferrara, G Grassi, F A Grassi, et al.
Giornale Italiano Di Chemioterapia|January 1, 1989
[In vitro antibacterial activity of neomycin, bacitracin and a combination of both]A Ferrara, G Grassi, P D Piccioni, et al.
The Journal of Hospital Infection|March 1, 1986
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organismsA Fietta, C Bersani, V De Rose, et al.
Thorax|October 1, 1996
An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory SocietyT Schaberg, G Gialdroni-Grassi, G Huchon, et al.
Infection|May 1, 1994
Flurithromycin ethylsuccinate in the treatment of lower respiratory tract bacterial infectionsF Bariffi, V Clini, F Ginesu, et al.
The American Review of Respiratory Disease|October 1, 1988
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration studyG Acocella, A Nonis, G Perna, et al.
Giornale Italiano Di Chemioterapia|January 1, 1987
[Changes in monocyte chemotaxis in patients with primary lung neoplasia]C Merlini, A Fietta, C Bersani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
In vitro activity of flurithromycin, a novel macrolide antibioticG Gialdroni Grassi, R Alesina, C Bersani, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 1, 1995
In vitro effect of bombesin-related peptides on the procoagulant activity of alveolar macrophagesF Meloni, A Saporiti, P Ballabio, et al.
Chemotherapy|July 1, 1995
Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytesF Meloni, P Ballabio, L Bianchi, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Bactericidal activity of meropenem and interactions with other antibioticsA Ferrara, G Grassi, F A Grassi, et al.
Giornale Italiano Di Chemioterapia|January 1, 1989
[In vitro antibacterial activity of neomycin, bacitracin and a combination of both]A Ferrara, G Grassi, P D Piccioni, et al.
The Journal of Hospital Infection|March 1, 1986
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organismsA Fietta, C Bersani, V De Rose, et al.
Thorax|October 1, 1996
An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory SocietyT Schaberg, G Gialdroni-Grassi, G Huchon, et al.
Infection|May 1, 1994
Flurithromycin ethylsuccinate in the treatment of lower respiratory tract bacterial infectionsF Bariffi, V Clini, F Ginesu, et al.
The American Review of Respiratory Disease|October 1, 1988
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration studyG Acocella, A Nonis, G Perna, et al.
Giornale Italiano Di Chemioterapia|January 1, 1987
[Changes in monocyte chemotaxis in patients with primary lung neoplasia]C Merlini, A Fietta, C Bersani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
In vitro activity of flurithromycin, a novel macrolide antibioticG Gialdroni Grassi, R Alesina, C Bersani, et al.
Pageof 8